Firefly Neuroscience
AIFF
12 hedge funds and large institutions have $597K invested in Firefly Neuroscience in 2024 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
52% more capital invested
Capital invested by funds: $393K → $597K (+$204K)
33% more funds holding
Funds holding: 9 → 12 (+3)
0.89% more ownership
Funds ownership: 1.76% → 2.65% (+0.89%)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$204K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$51.1K |
| 3 |
State Street
Boston,
Massachusetts
|
+$43.1K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$35.1K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$8.94K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$42.2K |
| 2 |
WC
Wexford Capital
West Palm Beach,
Florida
|
-$2.92K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$512 |
| 4 |
CA
Continuum Advisory
Eagle,
Idaho
|
-$68 |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$68 |
AIFF Hedge Fund Activity: Q4 2024 in Review
12 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Firefly Neuroscience (AIFF) for Q4 2024, worth a combined $597K — up 52% from $393K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new AIFF positions and 1 closed out — a net gain of 3 holders — while 3 added to existing stakes and 4 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $204K. The largest seller was Millennium Management, cutting an estimated $42.2K.
- 12 institutional investors held Firefly Neuroscience (AIFF) as of Q4 2024, up from 9 in Q3 2024.
- Funds reported $597K of Firefly Neuroscience stock for Q4 2024, up 52% quarter-over-quarter.
- 4 funds opened new Firefly Neuroscience positions in Q4 2024 and 1 closed out, a net change of +3 holders.
- The largest Firefly Neuroscience buyer in Q4 2024 was Vanguard Group, an estimated $204K added.
- The largest Firefly Neuroscience seller in Q4 2024 was Millennium Management, an estimated $42.2K sold.
Based on aggregated 13F filings for Q4 2024.